SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?


To: imdchamps who wrote (34292)11/3/2000 10:15:21 AM
From: DownSouth  Respond to of 54805
 
champ, UF is a LEAPS Substitution Therapy fan, or was. You say buying ITM LEAPS seems conservative. It is only if the stock price doesn't fall dramatically, i.e. QCOM.

UF and I can teach you a thing or two about LEAPS after this year! Yuk!



To: imdchamps who wrote (34292)11/3/2000 1:52:20 PM
From: Uncle Frank  Read Replies (1) | Respond to of 54805
 
I have used LEAPS substitution therapy on several occasions, with mixed results. The problem arises when the underlying crashes, a la Q. In an ugly situation such as that, the LEAPS lose a much higher percentage of their value than the stock - negative leverage. And even if the stock rises, LEAPS are not long term instruments so you will need to sell or exercise them in 12 - 18 months.

Bottom line, if you can handle the volatility of LEAPS, they represent the best method I know of to increase leverage while avoiding the perils of margin.

uf